David Sidransky's Net Worth

$3.94 Million

Who is David Sidransky?

David Sidransky has an estimated net worth of $3.94 Million. This is based on reported shares across multiple companies, which include ALFACELL CORP, KV PHARMACEUTICAL CO /DE/, CHAMPIONS BIOTECHNOLOGY, INC., Cactus Acquisition Corp. 1 Ltd, Celsus Therapeutics Plc., Advaxis, Inc., Orgenesis Inc., Ayala Pharmaceuticals, Inc., IMMUNE PHARMACEUTICALS INC, IMCLONE SYSTEMS INC/DE, and ZILA INC.

SEC CIK

David Sidransky's CIK is 0001277161

Past Insider Trading and Trends

2014 was David Sidransky's most active year for acquiring shares with 9 total transactions. David Sidransky's most active month to acquire stocks was the month of October. 2016 was David Sidransky's most active year for disposing of shares, totalling 2 transactions. David Sidransky's most active month to dispose stocks was the month of September. 2018 saw David Sidransky paying a total of $133,061.07 for 126,733 shares, this is the most they've acquired in one year. In 2016 David Sidransky cashed out on 22,808 shares for a total of $342,348.08, their largest year based on trade value.